Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer (Q40332582)
Jump to navigation
Jump to search
scientific article published on January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer |
scientific article published on January 2010 |
Statements
1 reference
Prospective multicenter randomized phase III study of weekly versus standard docetaxel plus doxorubicin (D4) for first-line treatment of metastatic breast cancer (English)
1 reference
Ursula Vehling Kaiser
1 reference
Hans-Joachim Stemmler
1 reference
Nadia Harbeck
1 reference
Isolde Gröll de Rivera
1 reference
Gerhard Rauthe
1 reference
Wolfgang Abenhardt
1 reference
Almut Artmann
1 reference
Hans-Gerd Meerpohl
1 reference
Marion Kiechle
1 reference
Volker Heinemann
1 reference
1 January 2010
1 reference
1 reference
79
1 reference
3-4
1 reference
204-210
1 reference
Identifiers
1 reference
1 reference